跳至主要内容
临床试验/CTRI/2022/08/044660
CTRI/2022/08/044660尚未招募不适用

A Comparative evaluation of intrathecal hyperbaric ropivacaine versus hyperbaric bupivacaine in elective surgery under spinal anaesthesia

GCS Medical College hospital and researah centre1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年5月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
To assess between Ropivacaine and Bupivacaine which has less cardiac and neurological complication

研究概览

简要总结

A Comparative Evaluation of IntrathecalHyperbaricRopivacaineversus HyperbaricBupivacaine in Elective Surgery UnderSpinalAnaesthesia

Aims and Objective :

Tocompare the anaesthetic and analgesic efficacy of  Intrathecal Hyperbaric  Ropivacaine and Hyperbaric Bupivacaine in patients posted for surgeries underspinal anaesthesia. Primary objective is toevaluate the efficacyand safety of hyperbaricRopivacaine forNeuraxial  blockade compared to hyperbaric Bupivacaine and the secondary objective is tocompare the relative advantages and disadvantages of both the drugs, onset andduration of anaesthesia, perioperative hemodynamic and any adverse effects.

 Material and methods:

•ProspectiveRandomizedControlledStudy

•Total= 200 patients. ASAgrade I and II arerandomlyselected for the study and  dividedinto two groups of 100each.

•Twogroups Group B - receive3.5 ml of0.5% hyperbaric bupivacaine intrathecally.

•GroupR  - receive 3.5 ml of 0.75% hyperbaric ropivacaine intrathecally.

•Onsetand extent of sensory block, onset and duration of motor block, the maximum heightof sensory block, and duration of analgesia, hemodynamic parameters and adverseeffects if any are studied.

conclusion:

Ropivacainehas less cardio toxicity and neurotoxicity than Bupivacaine

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Patient with informed consent Age between 18 to 75 Years BMI<30kg/m2 ASA I & II Infra umbilical Surgery <3 hours.

排除标准

  • Patient who will not give consent BMI>30kg/m2 ASA III & IV Contraindication to spinal anaesthesia Known Allergy to Ropivacaine or any other local Anaesthetic Agent Duration of Surgery > 3hours Patients on chronic Anticoagulation or Antiplatelet drugs.

结局指标

主要结局

To assess between Ropivacaine and Bupivacaine which has less cardiac and neurological complication

时间窗: immediate after giving spinal anaesthesia

次要结局

  • To assess the Hemodynamics parameters and the regression of motor and sensory effects between ropivacaine and bupivacaine(After 4 hours of giving spinal anaesthesia)

研究者

发起方
GCS Medical College hospital and researah centre
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验